Ecto-5′-nucleotidase is not required for ischémie preconditioning in rabbit myocardium in situ

American Journal of Physiology

Volumn 275, Issue 4 PART2, 1998, Pages

  Miki, Takayuki ^a   Miura, Tetsuji ^b   Hunger, Rolf ^a   Suzuki, Katsuo ^a   Sakamoto, Jun ^b   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

8 phenyltheophylline; A, methylene adenosine diphosphate; Adenosine; Adenosine 5' moriophosphate; In situ heart; Myocardial infarct size

Indexed keywords

ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ECTO 5' NUCLEOTIDASE; THEOPHYLLINE DERIVATIVE;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; CHRONOTROPISM; CONDITIONING; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INOTROPISM; MALE; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ANIMALS; BLOOD PRESSURE; ENZYME INHIBITORS; HEART; HEART RATE; ISCHEMIC PRECONDITIONING; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIUM; RABBITS; RECEPTORS, PURINERGIC P1; THEOPHYLLINE;

EID: 0031782630     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Borgers, M., and F. Thone. Species differences in adenosine metabolic sites in the heart. Histochem. J. 24:445-452,1992.
2. Hunger, R., F. J. Haddy, and E. Gerlach. Coronary responses to dilating substances and competitive inhibition by theophylline in the isolated perfused guinea pig heart. Pflügers Arch. 358: 213-224,1975.
3. Bünger, R., and S. Soboll. Cytosolic adenylates and adenosine release in perfused working heart. Comparison of whole tissue with cytosolic non-aqueous fraction analyses. Eur. J. Biochem. 159:203-213,1986.
4. Chaudry, I. H. Does ATP cross the cell plasma membrane? Yale J. Biol. Med. 55:1-10,1982.
5. Deussen, A., B. Banding, M. Keim, and J. Schrader. Formation and salvage of adenosine by macrovascular endothelial cells. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H692-H700,1993.
6. Downey, J. M., and T. Miura. The role of adenosine in ischémie preconditioning. In: Cardiac Adaptation and Failure, edited by M. Hori, Y. Maruyama, and R. S. Reneman. Tokyo: Springer, 1994, p. 147-166.
7. Finegan, B. A., H.-J. Chen, Y. N. Singh, and A. S. Clanachan. Comparison of hemodynamic changes induced by adenosine monophosphate and sodium nitroprusside alone and during dopamine infusion in the anesthetized dog. Anesth. Analg. 70: 44-52,1990.
8. Goto, M., Y. Liu, X.-M. Yang, J. L. Ardell, M. V. Cohen, and J. M. Downey. Role of bradykinin in protection of ischémie preconditioning in rabbit hearts. Circ. Res. 77:611-621,1995.
9. Goto, M., T. Miura, E. K. Iliodoromitis, E. L. O'Leary, R. Ishimoto, and O. limura. Adenosine infusion during early reperfusion failed to limit myocardial infarct size in collateral deficient species. Cardiovasc. Res. 25: 943-949,1991.
10. Griffith, S. G., P. Meghji, C. J. Moody, and G. Burnstock. 8-Phenyltheophylline: a potent Pl-purinoceptor antagonist. Eur. J. Pharmacol. 75:61-64,1981.
11. Haessler, R., K. Kuzume, R. A. Wolff, K. Kuzume, G. L. Chien, R. F. Davis, and D. M. Van Winkle. Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischémie preconditioning. Coron. Artery Dis. 7: 305-314.1996.
12. Headrick, J. P., G. P. Matherne, and R. M. Berne. Myocardial adenosine formation during hypoxia: effects of ecto-5'-nucleotidase inhibition. J. Mol. Cell. Cardiol. 24:295-303,1992.
13. Imai, S., W. P. Chin, H. Jin, and M. Nakazawa. Production of AMP and adenosine in the interstitial fluid compartment of the isolated perfused normoxic guinea pig heart. Pflügers Arch. 414: 443-449,1989.
14. Kitakaze, M., M. Hori, T. Morioka, T. Minamino, S. Takashima, H. Sato, Y. Shinozaki, M. Chujo, H. Mori, M. Inoue, and T. Kamada. Infarct size-limiting effect of ischémie preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release. Circulation 89: 12371246,1994.
15. Kitakaze, M., M. Hori, T. Morioka, T. Minamino, S. Takashima, H. Sato, Y. Shinozaki, M. Chujo, H. Mori, M. Inoue, and T. Kamada. Alphal-adrenoceptor activation mediates the infarct size-limiting effect of ischémie preconditioning through augmentation of 5'-nucleotidase activity. J. Clin. Invest. 93:2197-2205,1994.
16. Kitakaze, M., M. Hori, S. Takashima, H. Sato, M. Inoue, and T. Kamada. Ischémie preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs: implication for myocardial salvage. Circulation 87: 208-215,1993.
17. Lasley, R. D., P. J. Konyn, J. O. Hegge, and R. M. Mentzer, Jr. Effects of ischémie and adenosine preconditioning on interstitial fluid adenosine and-myocardial infarct size. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1460-H1466,1995.
18. Li, Y., and R. A. Kloner. The cardioprotective effects of ischémie "preconditioning" are not mediated by adenosine receptors in rat hearts. Circulation 87:1642-1648,1993.
19. Lloyd, H. G. E., and J. Schrader. Adenosine metabolism in the guinea pig heart: the role of cytosolic S-adenosyl-L-homocysteine hydrolase, 5'-nucleotidase and adenosine kinase. Eur. Heart. J. 14, Suppl. 1:27-33,1993.
20. Mallet, R. T., J. Sun, W.-L. Fan, Y.-H. Kang, and R. Hunger. Magnesium activated adenosine formation in intact perfused heart: predominance of ecto 5'-nucleotidase during hypermagnasemia. Biochim. Biophys. Ada 1290:165-176,1996.
21. Miura, T., T. Ogawa, T. Iwamoto, K. Shimamoto, and O. limura. Dipyridamole potentiates the myocardial infarct sizelimiting effect of ischémie preconditioning. Circulation 86: 979985,1992.
22. Miura, T., K. Suzuki, K. Shimamoto, and O. limura. Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning. Basic Res. Cardiol. 91:425-432,1996.
23. Mukohara, N., Y.-H. Kang, and R. Bünger. Magnesiuminduced coronary dilation and adenosine. a,β-Methylene adenosine 5'-diphosphate attenuation and theophylline paradox. Pharm. Pharmacol. Lett. 2:12-15,1992.
24. Nakano, A., T. Miura, N. Ura, K. Suzuki, and K. Shimamoto. Role of the angiotensin II type 1 receptor in preconditioning against infarction. Coron. Artery Dis. 8:343-350,1997.
25. Olafsson, B, M. B. Forman, D. W. Puett, A. Pou, C. U. Gates, G. C. Friesinger, and R. Virmani. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon. Circulation 76:1135-1145,1987.
26. Olsson, R. A., and J. D. Pearson. Cardiovascular purinoceptors. Physiol. Rev. 70: 761-845,1990.
27. Pelleg, A, T. Mitsuoka, E. L. Michelson, and H. Menduke. Adenosine mediates the negative chronotropic action of adenosine 5'-triphosphate in the canine sinus node. J. Pharmacol. Exp. Ther. 242: 791-795,1987.
28. Pridjian, A. K., E. L. Bove, S. F. Boiling, K. F. Childs, K. M. Brosamer, and F. M. Lupinetti. Developmental differences in myocardial protection in response to 5'-nucleotidase inhibition. J. Thorac. Cardiovasc. Surg. 107:520-526,1994.
29. Raatikainen, M. J. P., K. J. Peuhkurinen, and I. E. Hassinen. Contribution of endothelium and cardiomyocytes to hypoxia-induced adenosine release. J. Mol. Cell. Cardiol. 26: 10691080,1994.
30. Schutz, W., J. Schrader, and E. Gerlach. Different sites of adenosine formation in the heart. Am. J. Physiol. 240 (Heart Circ. Physiol. 9): H963-H970,1981.
31. Schwann, T. A., K. W. Lobdell, J. Braxton, S. Condos, J. C. Baldwin, and G. S. Kopf. 5'-Nucleotidase inhibition enhances postischemic myocardial performance. J. Surg. Res. 56:356-360, 1994.
32. Thornton, J. D., J. F. Daly, M. V. Cohen, X.-M. Yang, and J. M. Downey. Catecholamines can induce adenosine receptormediated protection of the myocardium but do not participate in ischémie preconditioning in the rabbit. Circ. Res. 73: 649-655, 1993.
33. Tsuchida, A., T. Miura, T. Miki, K. Shimamoto, and O. limura. Role of adenosine receptor activation in infarct size limitation by preconditioning in the heart. Cardiovasc. Res. 26: 456-461,1992.
34. Vander Heide, R. S., and K. A. Reimer. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs. Cardiovasc. Res. 31: 711-718,1996.
35. Van Wylen, D. G. L. Effect of ischémie preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 89:2283-2289,1994.
36. Wilde, A. A. M., R. J. G. Peters, and M. J. Janse. Catecholamine release and potassium accumulation in the isolated globally ischémie rabbit heart. J. Mol. Cell. Cardiol. 20:887-896, 1988.
37. Yamazaki, Y., V. L. Truong, and J. M. Lowenstein. 5'Nucleotidase I from rabbit heart. Biochemistry 30: 1503-1509, 1991.
38. 2390,1994.
39. Zimmermann, H. 5'-Nucleotidase: molecular structure, and functional aspects. Biochem. J. 285:345-365,1992.